Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis
Author:
Publisher
Elsevier BV
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference15 articles.
1. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2016
2. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA;Agrawal;Clin Rheumatol,2007
3. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome;Quinn;Rheumatology (Oxford),2006
4. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis;Barra;J Rheumatol,2014
5. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment;Lal;Arthritis Rheum,2011
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments;Journal of Nanobiotechnology;2023-03-25
2. A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases;RMD Open;2022-09
3. Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statements;Expert Opinion on Drug Safety;2021-12-29
4. Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA;Rheumatology and Therapy;2021-12-23
5. Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies;Reumatologia/Rheumatology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3